Attovia Therapeutics Inc recorded a single notable purchase during the past ninety days. Frazier Life Sciences XI, L.P. acquired 588,235 shares valued at approximately 9.99 million dollars on August 6, 2026. This solitary transaction represents the entirety of recent insider trading activity for the firm, occurring without any corresponding public disclosure regarding recent results financiers.